Eyenovia Inc (EYEN)
0.1197
-0.04
(-23.76%)
USD |
NASDAQ |
Jan 08, 16:00
0.1152
0.00 (0.00%)
After-Hours: 20:00
Eyenovia Research and Development Expense (Annual): 12.98M for Dec. 31, 2023
Research and Development Expense (Annual) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Annual) Benchmarks
TFF Pharmaceuticals Inc | 12.06M |
Johnson & Johnson | 15.08B |
Merck & Co Inc | 30.53B |
Aptevo Therapeutics Inc | 17.11M |
Amneal Pharmaceuticals Inc | 167.78M |